Towards biomarker-driven therapies for gastroesophageal cancer: A changing landscape

Research output: PhD ThesisPhd-Thesis - Research and graduation internal

Abstract

Resectable gastroesophageal cancer has a poor outcome with a five-year survival rate of approximately 20%. Different treatment strategies based on chemotherapy or chemoradiotherapy are utilized across the globe. These therapies are given without stratification for patient or tumor characteristics. In this thesis we first conducted multiple literature reviews with (network) meta
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Amsterdam
Supervisors/Advisors
  • van Laarhoven, Hanneke, Supervisor
  • Bijlsma, Maarten, Supervisor
  • de Gruijl, Tanja, Co-supervisor, External person
  • Mouliere, Florent, Co-supervisor, External person
  • van Laarhoven, H.W.M., Supervisor, External person
  • de Gruijl, T.D., Co-supervisor, External person
  • Moulière, F.C., Co-supervisor, External person
Award date12 Dec 2023
Print ISBNs9789464199727
Publication statusPublished - 2023

Cite this